Wells Fargo analyst Mike Mayo maintained a Buy rating on Citigroup (C – Research Report) today and set a price target of $95.00. The ...

Citi initiates coverage of Gilead Sciences and Vertex Pharmaceuticals at buy in the large U.S. biotech sector. Read more here.

Citigroupa expanded its biotech coverage on Wednesday, adding five more stocks to the roster including Amgen (NASDAQ:AMGN), ...

Producers of dynamic random access memory, or DRAM, which includes Micron Technology, Samsung and SK Hynix, should see ...

Many or all of the products on this page are from partners who compensate us when you click to or take an action on their website, but this does not influence our evaluations or ratings.

Large Cap financials underperformed for much of the last two years The biggest banks also have strong brokerage units ...

Citi initiated coverage of CSW Industrials (CSWI) with a Neutral rating and $466 price target CSW has a “resilient” business model and its focus on high-demand sustainability products should drive ...

Citigroup Chief Executive Jane Fraser That's Citigroup Inc ... from Dow Jones Newswires and The Wall Street Journal. We sell different types of products and services to both investment professionals ...

We recently compiled a list of the Jim Cramer Talked About These 16 Stocks. In this article, we are going to take a look at where Citigroup Inc. (NYSE:C) stands against the other stocks Jim Cramer was ...

Citigroup Inc. Chief Executive Officer Jane Fraser said that clients who’d been waiting on the sidelines to do deals are ...

The company has a Momentum Grade of C, based on its Momentum Score of 49. This means that the stock’s momentum is average in ...

Vis Raghavan, the man charged with reviving Citigroup’s reputation as an investment bank, is setting his sights on the buyout kings. The former JPMorgan executive wants dealmakers to advise on, and ...